Publications

Glover C, Crawford N, Leeb A, Wood N, Macartney K. Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety. Vaccine. 2020;38:4892-4900 . [Abstract]

Estcourt MJ, Campbell DE, Gold MS, Richmond P, Allen KJ, Quinn HE, Marsh JA, Peters RL, Valerio C, Dai D, Waddington CS, Wood NJ, McIntyre PB, Holt PG, Snelling TL. Whole cell pertussis vaccination and decreased risk of IgE-mediated food allergy: a nested case-control study. The Journal of Allergy and Clinical Immunology: In Practice. 2020;8:2004-2014 doi: https://doi.org/10.1016/j.jaip.2019.12.020 . [Abstract ]

McRae JE, Quinn HE, Saravanos GL, Carlson SJ, Britton PN, Crawford NW, Wood NJ, Marshall HS, Macartney KK on behalf of the PAEDS network. Paediatric Active Enhanced Disease Surveillance (PAEDS) 2017 and 2018: Prospective hospital-based surveillance. Communicable Diseases Intelligence. 2020;44 . [Full text]

Meder K, Jayasinghe S, Beard F, Dey A, Kirk M, Cook H, Strachan J, Sintchenko V, Smith H, Pennington K, Giele C, Howden B, Krause V, McIntyre P . Long-term impact of pneumococcal conjugate vaccines on invasive disease and pneumonia hospitalizations in Indigenous and non-Indigenous Australians. Clinical Infectious Diseases. 2020;70:2607-2615 . [Abstract]

Khatami A, Burrell R, McMullan BJ, Rawlinson W, Givney RC, Kok J, Alexandersen S, Jones CA, Macartney KK, Britton PN. Epidemic and inter-epidemic burden of paediatric human parechovirus infection in New South Wales, Australia, 2017-2018 . The Pediatric Infectious Disease Journal. 2020;39:507-11. doi: 10.1097/INF.0000000000002615. [Abstract]

Thielemans E, Oliver J, McMinn A, Baker C, Britton PN, Clark J, Marshall H, Blyth CC, Francis J, Buttery J, Smeesters PR, Crawford N, Steer AC. Clinical description and outcomes of Australian children With invasive group A streptococcal disease. The Pediatric Infectious Diseases Journal. 2020;39:379-384. doi: 10.1097/INF.0000000000002596 . [Abstract]

Litt J, Booy R, Bourke D, Dwyer DE, Leeb A, McCloud P, Stein AN, Woodward M, Cunningham AL. Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine. Human Vaccines & Immunotherapeutics. https://doi.org/10.1080/21645515.2020.1754702. [Full text]

Sharma K, Perrett K, Wood N. Case Series: Yellow fever vaccination in egg-allergic children. Pediatric Infectious Disease Journal. 2020;39:e76-e78. doi: 10.1097/INF.0000000000002625. [Full text]

Totterdell J, Phillips A, Glover C, Chidwick K, Marsh J, Snelling T, Macartney K. Safety of live attenuated herpes zoster vaccine in adults 70 to 79 years: a self-controlled case series analysis using primary care data from the MedicineInsight program. Vaccine. 2020;38:3968-3979 . [Full text]

Pillsbury AJ, Fathima P, Quinn HE, Cashman P, Blyth CC, Leeb A, Macartney K . Comparative post-market safety profile of adjuvanted and high-dose influenza vaccines in the elderly. JAMA Open. 2020;3(5):e204079 . [Full text]